AVIR
Atea Pharmaceuticals Inc.
$3.09
-$0.05(-1.59%)
52
Overall
60
Value
50
Tech
47
Quality
Market Cap
$235.69M
Volume
208.84K
52W Range
$2.46 - $4.02
Target Price
$6.00
EPS Estimates Overview
| Current Quarter | $-0.46 | Next Quarter | $-0.48 |
| Current Year | $-1.79 | Next Year | $-1.79 |
| QoQ Growth | -4.3% | YoY Growth | +0.0% |
| 3Y EPS CAGR | -49.9% | Target Price | $6.00 |
| Consensus | Buy | Upside | +94.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVIR | $3.09 | -1.6% | 208.84K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atea Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW